Fluicell
0.033
SEK
-19.9 %
FLUI
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
4 following
-19.9%
-43.3%
-57.91%
-63.25%
-77.55%
-82.28%
-99.24%
-98.22%
-98.96%
Fluicell is a biotechnology company. The company conducts research and development in processing the composition of cells in the development of new pharmaceuticals. The company has developed a product portfolio consisting of patented research instruments, which are used to study, analyze and finally process cells. In addition, there is expertise in 2D / 3D printing. Fluicell was founded in 2012 and is headquartered in Gothenburg.
Read moreMarket cap
15.87M SEK
Turnover
411.63K SEK
Revenue
3.34M
EBIT %
-804.79 %
P/E
-
Dividend yield-%
-
Financial calendar
7/3
2025
Annual report '24
9/5
2025
Interim report Q1'25
14/5
2025
General meeting '24
ShowingAll content types
Kommuniké från extra bolagsstämma i Fluicell AB (publ)
Fluicell beviljas patent i EU gällande plattformen Nexocyte
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools